Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1994 Oct 15;303(Pt 2):391–400. doi: 10.1042/bj3030391

Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.

L F Lau 1, K Pumiglia 1, Y P Côté 1, M B Feinstein 1
PMCID: PMC1137340  PMID: 7526841

Abstract

Synthetic thrombin receptor peptides (TRPs), comprising the first 6-14 amino acids of the new N-terminus tethered ligand of the thrombin receptor that is generated by thrombin's proteolytic activity, were reported to activate platelets equally with thrombin itself and are considered to be full agonists [Vu et al. (1991) Cell 64, 1057-1068]. Using aspirin plus ADP-scavengers or the ADP-receptor antagonist adenosine 5'-[alpha-thio]triphosphate to prevent the secondary effects of the potent agonists that are normally released from stimulated platelets (i.e. ADP and thromboxane A2), we assessed the direct actions of thrombin and TRPs (i.e. TRP42-47 and TRP42-55). Compared with thrombin, under these conditions, TRPs: (1) failed to aggregate platelets completely; (2) produced less activation of glycoprotein (GP)IIb-IIIa; (3) did not cause association of GPIIb and pp60c-src with the cytoskeleton; and (4) caused less alpha-granule secretion, phosphorylation of cytoplasmic phospholipase A2, arachidonic acid release and phosphatidyl inositol (PtdOH) production. Furthermore, TRPs induced transient increases in protein phosphorylation mediated by protein kinase C and protein tyrosine phosphorylation, whereas these same responses to thrombin were greater and more sustained. Hirudin added after thrombin accelerated protein dephosphorylation, thereby mimicking the rate of spontaneous dephosphorylation seen after stimulation by TRPs. Platelets totally desensitized to very high concentrations of TRPs, by prior exposure to maximally effective concentrations of the peptides, remained responsive to alpha- and gamma-thrombins. Thrombin-stimulated PtdOH production in permeabilized platelets desensitized to TRPs was abolished by guanosine 5'-[beta-thio]diphosphate (GDP[beta S]), as in normal platelets. These results are discussed in terms of the allosteric Ternary Complex Model for G-protein linked receptors [Samama et al. (1993) J. Biol. Chem. 268, 4625-4636]. We conclude that: (1) TRPs are partial agonists for the thrombin receptor and produce incomplete receptor desensitization in keeping with their lower intrinsic activity; (2) thrombin's effects in platelets, even in TRP-desensitized platelets, are entirely mediated through the recently cloned G-protein linked receptor, and (3) thrombin's ability to produce sustained signals, compared with TRPs, may require the continued progressive proteolytic activation of naive thrombin receptors.

Full text

PDF
391

Images in this article

395Figure 3
on p.395

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benovic J. L., Staniszewski C., Mayor F., Jr, Caron M. G., Lefkowitz R. J. beta-Adrenergic receptor kinase. Activity of partial agonists for stimulation of adenylate cyclase correlates with ability to promote receptor phosphorylation. J Biol Chem. 1988 Mar 15;263(8):3893–3897. [PubMed] [Google Scholar]
  2. Brass L. F. Homologous desensitization of HEL cell thrombin receptors. Distinguishable roles for proteolysis and phosphorylation. J Biol Chem. 1992 Mar 25;267(9):6044–6050. [PubMed] [Google Scholar]
  3. Brass L. F., Pizarro S., Ahuja M., Belmonte E., Blanchard N., Stadel J. M., Hoxie J. A. Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J Biol Chem. 1994 Jan 28;269(4):2943–2952. [PubMed] [Google Scholar]
  4. Brass L. F., Vassallo R. R., Jr, Belmonte E., Ahuja M., Cichowski K., Hoxie J. A. Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus. J Biol Chem. 1992 Jul 15;267(20):13795–13798. [PubMed] [Google Scholar]
  5. Carney D. H., Mann R., Redin W. R., Pernia S. D., Berry D., Heggers J. P., Hayward P. G., Robson M. C., Christie J., Annable C. Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J Clin Invest. 1992 May;89(5):1469–1477. doi: 10.1172/JCI115737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chao B. H., Kalkunte S., Maraganore J. M., Stone S. R. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor. Biochemistry. 1992 Jul 14;31(27):6175–6178. doi: 10.1021/bi00142a001. [DOI] [PubMed] [Google Scholar]
  7. Coller B. S., Ward P., Ceruso M., Scudder L. E., Springer K., Kutok J., Prestwich G. D. Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M. Biochemistry. 1992 Dec 1;31(47):11713–11720. doi: 10.1021/bi00162a007. [DOI] [PubMed] [Google Scholar]
  8. De Lean A., Stadel J. M., Lefkowitz R. J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem. 1980 Aug 10;255(15):7108–7117. [PubMed] [Google Scholar]
  9. De Marco L., Mazzucato M., Masotti A., Ruggeri Z. M. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem. 1994 Mar 4;269(9):6478–6484. [PubMed] [Google Scholar]
  10. Greco N. J., Jamieson G. A. High and moderate affinity pathways for alpha-thrombin-induced platelet activation. Proc Soc Exp Biol Med. 1991 Dec;198(3):792–799. doi: 10.3181/00379727-198-43321d. [DOI] [PubMed] [Google Scholar]
  11. Greco N. J., Yamamoto N., Jackson B. W., Tandon N. N., Moos M., Jr, Jamieson G. A. Identification of a nucleotide-binding site on glycoprotein IIb. Relationship to ADP-induced platelet activation. J Biol Chem. 1991 Jul 25;266(21):13627–13633. [PubMed] [Google Scholar]
  12. Halenda S. P., Banga H. S., Zavoico G. B., Lau L. F., Feinstein M. B. Synergistic release of arachidonic acid from platelets by activators of protein kinase C and Ca2+ ionophores. Evidence for the role of protein phosphorylation in the activation of phospholipase A2 and independence from the Na+/H+ exchanger. Biochemistry. 1989 Sep 5;28(18):7356–7363. doi: 10.1021/bi00444a031. [DOI] [PubMed] [Google Scholar]
  13. Holmsen H., Dangelmaier C. A., Holmsen H. K. Thrombin-induced platelet responses differ in requirement for receptor occupancy. Evidence for tight coupling of occupancy and compartmentalized phosphatidic acid formation. J Biol Chem. 1981 Sep 25;256(18):9393–9396. [PubMed] [Google Scholar]
  14. Hoxie J. A., Ahuja M., Belmonte E., Pizarro S., Parton R., Brass L. F. Internalization and recycling of activated thrombin receptors. J Biol Chem. 1993 Jun 25;268(18):13756–13763. [PubMed] [Google Scholar]
  15. Huang E. M., Detwiler T. C. Thrombin-induced phosphoinositide hydrolysis in platelets. Receptor occupancy and desensitization. Biochem J. 1987 Feb 15;242(1):11–18. doi: 10.1042/bj2420011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Huang R. S., Sorisky A., Church W. R., Simons E. R., Rittenhouse S. E. "Thrombin" receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides. J Biol Chem. 1991 Oct 5;266(28):18435–18438. [PubMed] [Google Scholar]
  17. Hung D. T., Vu T. K., Wheaton V. I., Charo I. F., Nelken N. A., Esmon N., Esmon C. T., Coughlin S. R. "Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure. J Clin Invest. 1992 Feb;89(2):444–450. doi: 10.1172/JCI115604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hung D. T., Vu T. K., Wheaton V. I., Ishii K., Coughlin S. R. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J Clin Invest. 1992 Apr;89(4):1350–1353. doi: 10.1172/JCI115721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ishii K., Chen J., Ishii M., Koch W. J., Freedman N. J., Lefkowitz R. J., Coughlin S. R. Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. J Biol Chem. 1994 Jan 14;269(2):1125–1130. [PubMed] [Google Scholar]
  20. Ishii K., Hein L., Kobilka B., Coughlin S. R. Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J Biol Chem. 1993 May 5;268(13):9780–9786. [PubMed] [Google Scholar]
  21. Jandrot-Perrus M., Didry D., Guillin M. C., Nurden A. T. Cross-linking of alpha and gamma-thrombin to distinct binding sites on human platelets. Eur J Biochem. 1988 Jun 1;174(2):359–367. doi: 10.1111/j.1432-1033.1988.tb14106.x. [DOI] [PubMed] [Google Scholar]
  22. Jandrot-Perrus M., Rendu F., Caen J. P., Levy-Toledano S., Guillin M. C. The common pathway for alpha- and gamma-thrombin-induced platelet activation is independent of GPIb: a study of Bernard-Soulier platelets. Br J Haematol. 1990 Jul;75(3):385–392. doi: 10.1111/j.1365-2141.1990.tb04353.x. [DOI] [PubMed] [Google Scholar]
  23. Joseph S., MacDermot J. The N-terminal thrombin receptor fragment SFLLRN, but not catalytically inactive thrombin-derived agonists, activate U937 human monocytic cells: evidence for receptor hydrolysis in thrombin-dependent signalling. Biochem J. 1993 Mar 1;290(Pt 2):571–577. doi: 10.1042/bj2900571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kinlough-Rathbone R. L., Rand M. L., Packham M. A. Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets. Blood. 1993 Jul 1;82(1):103–106. [PubMed] [Google Scholar]
  25. Kjelsberg M. A., Cotecchia S., Ostrowski J., Caron M. G., Lefkowitz R. J. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem. 1992 Jan 25;267(3):1430–1433. [PubMed] [Google Scholar]
  26. Kramer R. M., Roberts E. F., Manetta J. V., Hyslop P. A., Jakubowski J. A. Thrombin-induced phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in human platelets. J Biol Chem. 1993 Dec 15;268(35):26796–26804. [PubMed] [Google Scholar]
  27. Lenormand P., Sardet C., Pagès G., L'Allemain G., Brunet A., Pouysségur J. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J Cell Biol. 1993 Sep;122(5):1079–1088. doi: 10.1083/jcb.122.5.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lin L. L., Lin A. Y., Knopf J. L. Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6147–6151. doi: 10.1073/pnas.89.13.6147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lum H., Andersen T. T., Siflinger-Birnboim A., Tiruppathi C., Goligorsky M. S., Fenton J. W., 2nd, Malik A. B. Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization. J Cell Biol. 1993 Mar;120(6):1491–1499. doi: 10.1083/jcb.120.6.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. McNamara C. A., Sarembock I. J., Gimple L. W., Fenton J. W., 2nd, Coughlin S. R., Owens G. K. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest. 1993 Jan;91(1):94–98. doi: 10.1172/JCI116206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Muramatsu I., Laniyonu A., Moore G. J., Hollenberg M. D. Vascular actions of thrombin receptor peptide. Can J Physiol Pharmacol. 1992 Jul;70(7):996–1003. doi: 10.1139/y92-137. [DOI] [PubMed] [Google Scholar]
  32. Ngaiza J. R., Jaffe E. A. A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells. Biochem Biophys Res Commun. 1991 Sep 30;179(3):1656–1661. doi: 10.1016/0006-291x(91)91765-5. [DOI] [PubMed] [Google Scholar]
  33. Norton K. J., Scarborough R. M., Kutok J. L., Escobedo M. A., Nannizzi L., Coller B. S. Immunologic analysis of the cloned platelet thrombin receptor activation mechanism: evidence supporting receptor cleavage, release of the N-terminal peptide, and insertion of the tethered ligand into a protected environment. Blood. 1993 Oct 1;82(7):2125–2136. [PubMed] [Google Scholar]
  34. Pumiglia K. M., Feinstein M. B. Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Translocation of pp60c-src and integrin alpha IIb beta 3 (glycoprotein IIb/IIIa) is not required for aggregation, but is dependent on formation of large aggregate structures. Biochem J. 1993 Aug 15;294(Pt 1):253–260. doi: 10.1042/bj2940253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pumiglia K. M., Lau L. F., Huang C. K., Burroughs S., Feinstein M. B. Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide). Biochem J. 1992 Sep 1;286(Pt 2):441–449. doi: 10.1042/bj2860441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rasmussen U. B., Vouret-Craviari V., Jallat S., Schlesinger Y., Pagès G., Pavirani A., Lecocq J. P., Pouysségur J., Van Obberghen-Schilling E. cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett. 1991 Aug 19;288(1-2):123–128. doi: 10.1016/0014-5793(91)81017-3. [DOI] [PubMed] [Google Scholar]
  37. Reilly C. F., Connolly T. M., Feng D. M., Nutt R. F., Mayer E. J. Thrombin receptor agonist peptide induction of mitogenesis in CCL39 cells. Biochem Biophys Res Commun. 1993 Feb 15;190(3):1001–1008. doi: 10.1006/bbrc.1993.1148. [DOI] [PubMed] [Google Scholar]
  38. STEPHENSON R. P. A modification of receptor theory. Br J Pharmacol Chemother. 1956 Dec;11(4):379–393. doi: 10.1111/j.1476-5381.1956.tb00006.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sabo T., Gurwitz D., Motola L., Brodt P., Barak R., Elhanaty E. Structure-activity studies of the thrombin receptor activating peptide. Biochem Biophys Res Commun. 1992 Oct 30;188(2):604–610. doi: 10.1016/0006-291x(92)91099-c. [DOI] [PubMed] [Google Scholar]
  40. Samama P., Cotecchia S., Costa T., Lefkowitz R. J. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem. 1993 Mar 5;268(7):4625–4636. [PubMed] [Google Scholar]
  41. Samama P., Pei G., Costa T., Cotecchia S., Lefkowitz R. J. Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor. Mol Pharmacol. 1994 Mar;45(3):390–394. [PubMed] [Google Scholar]
  42. Scarborough R. M., Naughton M. A., Teng W., Hung D. T., Rose J., Vu T. K., Wheaton V. I., Turck C. W., Coughlin S. R. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem. 1992 Jul 5;267(19):13146–13149. [PubMed] [Google Scholar]
  43. Scharpé S. L., Vanhoof G. C., De Meester I. A., Hendriks D. F., van Sande M. E., Muylle L. M., Yaron A. Exopeptidases in human platelets: an indication for proteolytic modulation of biologically active peptides. Clin Chim Acta. 1991 Jan 15;195(3):125–131. doi: 10.1016/0009-8981(91)90132-v. [DOI] [PubMed] [Google Scholar]
  44. Seiler S. M., Goldenberg H. J., Michel I. M., Hunt J. T., Zavoico G. B. Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor. Biochem Biophys Res Commun. 1991 Dec 16;181(2):636–643. doi: 10.1016/0006-291x(91)91238-8. [DOI] [PubMed] [Google Scholar]
  45. Seiler S. M., Michel I. M., Fenton J. W., 2nd Involvement of the "tethered-ligand" receptor in thrombin inhibition of platelet adenylate cyclase. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1296–1302. doi: 10.1016/0006-291x(92)91873-o. [DOI] [PubMed] [Google Scholar]
  46. Su Y. F., Harden T. K., Perkins J. P. Catecholamine-specific desensitization of adenylate cyclase. Evidence for a multistep process. J Biol Chem. 1980 Aug 10;255(15):7410–7419. [PubMed] [Google Scholar]
  47. Sugama Y., Malik A. B. Thrombin receptor 14-amino acid peptide mediates endothelial hyperadhesivity and neutrophil adhesion by P-selectin-dependent mechanism. Circ Res. 1992 Oct;71(4):1015–1019. doi: 10.1161/01.res.71.4.1015. [DOI] [PubMed] [Google Scholar]
  48. Sugama Y., Tiruppathi C., offakidevi K., Andersen T. T., Fenton J. W., 2nd, Malik A. B. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J Cell Biol. 1992 Nov;119(4):935–944. doi: 10.1083/jcb.119.4.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tam S. W., Fenton J. W., 2nd, Detwiler T. C. Dissociation of thrombin from platelets by hirudin. Evidence for receptor processing. J Biol Chem. 1979 Sep 25;254(18):8723–8725. [PubMed] [Google Scholar]
  50. Vassallo R. R., Jr, Kieber-Emmons T., Cichowski K., Brass L. F. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem. 1992 Mar 25;267(9):6081–6085. [PubMed] [Google Scholar]
  51. Vouret-Craviari V., Van Obberghen-Schilling E., Scimeca J. C., Van Obberghen E., Pouysségur J. Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist. Biochem J. 1993 Jan 1;289(Pt 1):209–214. doi: 10.1042/bj2890209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Vu T. K., Hung D. T., Wheaton V. I., Coughlin S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991 Mar 22;64(6):1057–1068. doi: 10.1016/0092-8674(91)90261-v. [DOI] [PubMed] [Google Scholar]
  53. Vu T. K., Wheaton V. I., Hung D. T., Charo I., Coughlin S. R. Domains specifying thrombin-receptor interaction. Nature. 1991 Oct 17;353(6345):674–677. doi: 10.1038/353674a0. [DOI] [PubMed] [Google Scholar]
  54. Warren W. C., Mustoe T. A., Glenn K. C. Tissue repair by thrombin-derived peptides in the rat. Pept Res. 1992 Nov-Dec;5(6):331–335. [PubMed] [Google Scholar]
  55. Wilhelm B., Siess W. Activation of the cloned platelet thrombin receptor decreases the pertussis-toxin-dependent ADP-ribosylation of the membrane and soluble inhibitory guanine-nucleotide-binding-alpha proteins. Inhibition by the prostacyclin analog, iloprost. Eur J Biochem. 1993 Aug 15;216(1):81–88. doi: 10.1111/j.1432-1033.1993.tb18119.x. [DOI] [PubMed] [Google Scholar]
  56. Yamamoto N., Greco N. J., Barnard M. R., Tanoue K., Yamazaki H., Jamieson G. A., Michelson A. D. Glycoprotein Ib (GPIb)-dependent and GPIb-independent pathways of thrombin-induced platelet activation. Blood. 1991 Apr 15;77(8):1740–1748. [PubMed] [Google Scholar]
  57. Zacharias U., He C. J., Nguyen G., Sraer J. D., Rondeau E. Long-term effects of thrombin require sustained activation of the functional thrombin receptor. FEBS Lett. 1993 Nov 15;334(2):225–228. doi: 10.1016/0014-5793(93)81716-d. [DOI] [PubMed] [Google Scholar]
  58. Zavoico G. B., Cragoe E. J., Jr, Feinstein M. B. Regulation of intracellular pH in human platelets. Effects of thrombin, A23187, and ionomycin and evidence for activation of Na+/H+ exchange and its inhibition by amiloride analogs. J Biol Chem. 1986 Oct 5;261(28):13160–13167. [PubMed] [Google Scholar]
  59. Zhong C., Hayzer D. J., Corson M. A., Runge M. S. Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vitro regulation by basic fibroblast growth factor. J Biol Chem. 1992 Aug 25;267(24):16975–16979. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES